Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. / Wiese, Signe; Danielsen, Karen V.; Busk, Troels; Hove, Jens D.; Ytting, Henriette; Hansen, Svend Høime; Andersen, Klaus Kaae; Voiosu, Andrei; Møller, Søren; Bendtsen, Flemming.

I: Alimentary Pharmacology and Therapeutics, Bind 58, Nr. 4, 08.2023, s. 453-462.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Wiese, S, Danielsen, KV, Busk, T, Hove, JD, Ytting, H, Hansen, SH, Andersen, KK, Voiosu, A, Møller, S & Bendtsen, F 2023, 'Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis', Alimentary Pharmacology and Therapeutics, bind 58, nr. 4, s. 453-462. https://doi.org/10.1111/apt.17533

APA

Wiese, S., Danielsen, K. V., Busk, T., Hove, J. D., Ytting, H., Hansen, S. H., Andersen, K. K., Voiosu, A., Møller, S., & Bendtsen, F. (2023). Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. Alimentary Pharmacology and Therapeutics, 58(4), 453-462. https://doi.org/10.1111/apt.17533

Vancouver

Wiese S, Danielsen KV, Busk T, Hove JD, Ytting H, Hansen SH o.a. Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. Alimentary Pharmacology and Therapeutics. 2023 aug.;58(4):453-462. https://doi.org/10.1111/apt.17533

Author

Wiese, Signe ; Danielsen, Karen V. ; Busk, Troels ; Hove, Jens D. ; Ytting, Henriette ; Hansen, Svend Høime ; Andersen, Klaus Kaae ; Voiosu, Andrei ; Møller, Søren ; Bendtsen, Flemming. / Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. I: Alimentary Pharmacology and Therapeutics. 2023 ; Bind 58, Nr. 4. s. 453-462.

Bibtex

@article{919db7bb05e44525bf849115a9d9dcc8,
title = "Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis",
abstract = "Background: Elevated serum bile acids (BA) are harmful to the heart and alterations in the BA composition have been suggested to cause cardiovascular disturbances in cirrhosis. Aim: To investigate any associations between specific groups or individual serum BA and structural and functional cardiac abnormalities in patients with cirrhosis. Methods: An explorative study in 86 patients with cirrhosis. All participants underwent extensive cardiac assessment, including cardiac MRI with quantification of myocardial extracellular volume (ECV), which is indicative of diffuse myocardial fibrosis. A panel of 15 individual serum BA and C4, a marker of de novo bile acid synthesis, were assessed. Results: Patients with advanced cirrhosis had higher levels of total BA and conjugated BA, as well as lower C4 levels (p < 0.001). Conjugated BA levels were higher in patients with a high cardiac index (p < 0.001), increased left atrial volume index (LAVI) (p < 0.001), and in those with an abnormal myocardial ECV (p < 0.05). We also found several strong correlations between conjugated BA, both as a group and individually, and parameters of cardiac dysfunction. In a model adjusted for sex, age, BMI and MELD, conjugated BA remained significantly associated with LAVI, septal e′, left ventricular volumes and cardiac index. In addition, taurocholic acid correlated closely with hepatic venous pressure gradient (HVPG) (p = 0.01). Conclusions: Increased serum concentrations of conjugated BA are associated with several cardiac parameters, indicating a potential role in the development of hyperdynamic circulation and cardiac dysfunction in cirrhosis. Moreover, taurine-conjugated BA are associated with portal hypertension.",
author = "Signe Wiese and Danielsen, {Karen V.} and Troels Busk and Hove, {Jens D.} and Henriette Ytting and Hansen, {Svend H{\o}ime} and Andersen, {Klaus Kaae} and Andrei Voiosu and S{\o}ren M{\o}ller and Flemming Bendtsen",
note = "Funding Information: The work was supported by grants from the Arvid Nilssons Foundation and the Capital Region of Denmark Foundation for Health Research. Funding Information: Andrei Voiosu: The contribution of AV to this work was supported in part by a grant of the Ministry of Research, Innovation and Digitization, CNCS—UEFISCDI, project number PN‐III‐P1‐1.1‐PD‐2021‐0180, within PNCDI III. None of the other authors have any conflicts of interest to be declared. Publisher Copyright: {\textcopyright} 2023 John Wiley & Sons Ltd.",
year = "2023",
month = aug,
doi = "10.1111/apt.17533",
language = "English",
volume = "58",
pages = "453--462",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis

AU - Wiese, Signe

AU - Danielsen, Karen V.

AU - Busk, Troels

AU - Hove, Jens D.

AU - Ytting, Henriette

AU - Hansen, Svend Høime

AU - Andersen, Klaus Kaae

AU - Voiosu, Andrei

AU - Møller, Søren

AU - Bendtsen, Flemming

N1 - Funding Information: The work was supported by grants from the Arvid Nilssons Foundation and the Capital Region of Denmark Foundation for Health Research. Funding Information: Andrei Voiosu: The contribution of AV to this work was supported in part by a grant of the Ministry of Research, Innovation and Digitization, CNCS—UEFISCDI, project number PN‐III‐P1‐1.1‐PD‐2021‐0180, within PNCDI III. None of the other authors have any conflicts of interest to be declared. Publisher Copyright: © 2023 John Wiley & Sons Ltd.

PY - 2023/8

Y1 - 2023/8

N2 - Background: Elevated serum bile acids (BA) are harmful to the heart and alterations in the BA composition have been suggested to cause cardiovascular disturbances in cirrhosis. Aim: To investigate any associations between specific groups or individual serum BA and structural and functional cardiac abnormalities in patients with cirrhosis. Methods: An explorative study in 86 patients with cirrhosis. All participants underwent extensive cardiac assessment, including cardiac MRI with quantification of myocardial extracellular volume (ECV), which is indicative of diffuse myocardial fibrosis. A panel of 15 individual serum BA and C4, a marker of de novo bile acid synthesis, were assessed. Results: Patients with advanced cirrhosis had higher levels of total BA and conjugated BA, as well as lower C4 levels (p < 0.001). Conjugated BA levels were higher in patients with a high cardiac index (p < 0.001), increased left atrial volume index (LAVI) (p < 0.001), and in those with an abnormal myocardial ECV (p < 0.05). We also found several strong correlations between conjugated BA, both as a group and individually, and parameters of cardiac dysfunction. In a model adjusted for sex, age, BMI and MELD, conjugated BA remained significantly associated with LAVI, septal e′, left ventricular volumes and cardiac index. In addition, taurocholic acid correlated closely with hepatic venous pressure gradient (HVPG) (p = 0.01). Conclusions: Increased serum concentrations of conjugated BA are associated with several cardiac parameters, indicating a potential role in the development of hyperdynamic circulation and cardiac dysfunction in cirrhosis. Moreover, taurine-conjugated BA are associated with portal hypertension.

AB - Background: Elevated serum bile acids (BA) are harmful to the heart and alterations in the BA composition have been suggested to cause cardiovascular disturbances in cirrhosis. Aim: To investigate any associations between specific groups or individual serum BA and structural and functional cardiac abnormalities in patients with cirrhosis. Methods: An explorative study in 86 patients with cirrhosis. All participants underwent extensive cardiac assessment, including cardiac MRI with quantification of myocardial extracellular volume (ECV), which is indicative of diffuse myocardial fibrosis. A panel of 15 individual serum BA and C4, a marker of de novo bile acid synthesis, were assessed. Results: Patients with advanced cirrhosis had higher levels of total BA and conjugated BA, as well as lower C4 levels (p < 0.001). Conjugated BA levels were higher in patients with a high cardiac index (p < 0.001), increased left atrial volume index (LAVI) (p < 0.001), and in those with an abnormal myocardial ECV (p < 0.05). We also found several strong correlations between conjugated BA, both as a group and individually, and parameters of cardiac dysfunction. In a model adjusted for sex, age, BMI and MELD, conjugated BA remained significantly associated with LAVI, septal e′, left ventricular volumes and cardiac index. In addition, taurocholic acid correlated closely with hepatic venous pressure gradient (HVPG) (p = 0.01). Conclusions: Increased serum concentrations of conjugated BA are associated with several cardiac parameters, indicating a potential role in the development of hyperdynamic circulation and cardiac dysfunction in cirrhosis. Moreover, taurine-conjugated BA are associated with portal hypertension.

U2 - 10.1111/apt.17533

DO - 10.1111/apt.17533

M3 - Journal article

C2 - 37098730

AN - SCOPUS:85153791664

VL - 58

SP - 453

EP - 462

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 4

ER -

ID: 369473192